Efficacy and safety of ibutilide for the conversion of monomorphic atrial tachycardia

PACE - Pacing and Clinical Electrophysiology

Volumn 29, Issue 4, 2006, Pages 358-362

  Eidher, Ulrike ^a,b   Freihoff, Fritz ^a   Kaltenbrunner, Wilhelm ^a   Steinbach, Konrad ^a  

^a LUDWIG BOLTZMANN INSTITUTE FOR LUNG VASCULAR RESEARCH   (Austria)

^b KAISER FRANZ JOSEF HOSPITAL   (Austria)

Author keywords

Arrhythmia; Ibutilide; Monomorphic atrial tachycardia; Torsade de pointes

Indexed keywords

AMIODARONE; ANTIARRHYTHMIC AGENT; FLECAINIDE; IBUTILIDE; SOTALOL;

ADULT; AGED; ARTICLE; BODY MASS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY CARE UNIT; DEFIBRILLATION; DISEASE DURATION; DRUG EFFICACY; DRUG FATALITY; DRUG SAFETY; ELECTROCARDIOGRAPHY MONITORING; EMBOLISM; FEMALE; GENDER; HEART ARRHYTHMIA; HEART ATRIUM FUNCTION; HEART BEAT; HEART DISEASE; HEART LEFT ATRIUM; HEART LEFT VENTRICLE FUNCTION; HEART RATE; HEART RHYTHM; HEART SIZE; HUMAN; INTENSIVE CARE UNIT; LUNG EMBOLISM; MALE; MULTIPLE DRUG DOSE; OPEN STUDY; OUTCOME ASSESSMENT; PATIENT MONITORING; SINGLE DRUG DOSE; SINUS RHYTHM; STROKE; SUPRAVENTRICULAR TACHYCARDIA; SYMPTOM; TORSADE DES POINTES;

ANTI-ARRHYTHMIA AGENTS; FEMALE; HUMANS; MALE; MIDDLE AGED; RISK ASSESSMENT; RISK FACTORS; SULFONAMIDES; TACHYCARDIA, ECTOPIC ATRIAL; TREATMENT OUTCOME;

EID: 33645720560     PISSN: 01478389     EISSN: 15408159     Source Type: Journal    
DOI: 10.1111/j.1540-8159.2006.00353.x     Document Type: Article

References (14)

1. Ellenbogen KA for the Ibutilide Investigators. Efficacy of intravenous ibutilide for rapid termination of atrial fibrillation and atrial flutter: A dose-response study. J Am Coll Cardiol 1996 28 130 136.
2. Stambler BS Wood MA Ellenbogen KA et al.. Efficacy and safety of repeated intravenous doses of ibutilide for rapid conversion of atrial flutter or fibrillation. Circulation 1996 94 1613 1621.
3. Ellenbogen KA Clemo HF Stambler BS et al.. Efficacy of ibutilide for termination of atrial fibrillation and flutter. Am J Cardiol 1996 78 Suppl. 8A 42 45.
4. + current in guinea pig ventricular cells. J Pharmacol Exp Ther 1992 262 99 108.
5. Kr) in AT-1 cells. Circulation 1995 91 1799 1806.
6. Stambler BS Wood MA Ellenbogen KA. Antiarrhythmic actions of intravenous ibutilide compared with procainamide during human atrial flutter and fibrillation. Circulation 1997 96 4298 4306.
7. Voglmann AS Carberry PA Stambler BS et al.. Conversion efficacy and safety of intravenous ibutilide compared with intravenous procainamide in patients with atrial flutter or fibrillation. J Am Coll Cardiol 1998 31 1414 1419.
8. Murray KT. Ibutilide: Review. Circulation 1998 97 493 497.
9. Roden DM. Ibutilide and the treatment of atrial arrhythmias. Circulation 1996 94 1499 1502.
10. Saoudi N Cosio F Waldo A et al.. A classification of atrial flutter and regular atrial tachycardia according to electrophysiological mechanisms and anatomical bases. Eur Heart J 2001 22 1162 1182.
11. Stein KM Markowitz SM Lermann BB. Atrial tachycardia. Cardiac Electrophysiol Rev 1997 1/2 67 70.
12. Stein KM Mittal S Slotwiner DJ et al.. Atrial tachycardia: Update. Cardiac Electrophysiol Rev 2001 5 290 293.
13. Glatter K Yanfei Y Chatterjee K et al.. Chemical conversion of atrial fibrillation or flutter with ibutilide in patients receiving amiodarone therapy. Circulation 2001 103 253 257.
14. Hongo RH Themistoclakis S Raviele A et al.. Use of ibutilide in cardioversion of patients with atrial fibrillation or atrial flutter treated with class Ic agents. J Am Coll Cardiol 2004 44 864 868.